Literature for K-7174 (XT01.001 inhibitor)
(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)
-
Kikuchi,J., Shibayama,N., Yamada,S., Wada,T., Nobuyoshi,M., Izumi,T., Akutsu,M., Kano,Y., Sugiyama,K., Ohki,M., Park,S.Y. and Furukawa,Y.
Homopiperazine derivatives as a novel class of proteasome inhibitors with a unique mode of proteasome binding
PLoS ONE (2013) 8, e60649-e60649. PubMed Europe PubMed DOI PMC EPMC I -
Kikuchi,J., Yamada,S., Koyama,D., Wada,T., Nobuyoshi,M., Izumi,T., Akutsu,M., Kano,Y. and Furukawa,Y.
The novel orally active proteasome inhibitor K-7174 exerts anti-myeloma activity in vitro and in vivo by down-regulating the expression of class I histone deacetylases
J Biol Chem (2013) 288, 25593-25602. PubMed Europe PubMed DOI I
2013
